Delayed Ischemic Neurological Deficit

Drug	Drug Name	Drug Description
DB00393	Nimodipine	A calcium channel blocker used to improve neurological outcomes in patients with subarachnoid hemorrhage due to a ruptured intracranial aneurysm.

Drug	Drug Name	Target	Type
DB00393	Nimodipine	Cytochrome P450 3A4	enzyme
DB00393	Nimodipine	Mineralocorticoid receptor	target
DB00393	Nimodipine	Voltage-dependent L-type calcium channel subunit alpha-1D	target
DB00393	Nimodipine	Voltage-dependent L-type calcium channel subunit alpha-1S	target
DB00393	Nimodipine	Voltage-dependent L-type calcium channel subunit alpha-1C	target
DB00393	Nimodipine	Voltage-dependent L-type calcium channel subunit beta-2	target
DB00393	Nimodipine	Voltage-dependent L-type calcium channel subunit alpha-1F	target
DB00393	Nimodipine	Voltage-dependent L-type calcium channel subunit beta-1	target
DB00393	Nimodipine	Voltage-dependent L-type calcium channel subunit beta-3	target
DB00393	Nimodipine	Voltage-dependent L-type calcium channel subunit beta-4	target
DB00393	Nimodipine	Aryl hydrocarbon receptor	target

Drug	Drug Name	Phase	Status	Count
DB16599	Cerebrolysin	2 / 3	Completed	1